High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection.
作者信息
Cappellano Giuseppe, Abreu Hugo, Raineri Davide, Scotti Lorenza, Castello Luigi, Vaschetto Rosanna, Chiocchetti Annalisa
出版信息
EMBO Mol Med. 2021 Nov 8;13(11):e15217. doi: 10.15252/emmm.202115217.
Abstract
摘要
相似文献
1
High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection.
EMBO Mol Med. 2021 Nov 8;13(11):e15217. doi: 10.15252/emmm.202115217.
2
High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection.
EMBO Mol Med. 2021 May 7;13(5):e14124. doi: 10.15252/emmm.202114124. Epub 2021 Mar 31.
3
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection.
BMC Infect Dis. 2024 Apr 12;24(1):398. doi: 10.1186/s12879-024-09280-6.
4
Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Front Immunol. 2022 Jun 24;13:893792. doi: 10.3389/fimmu.2022.893792. eCollection 2022.
5
Induction of a cytokine storm involves suppression of the Osteopontin-dependent TH1 response.
Immunology. 2022 Oct;167(2):165-180. doi: 10.1111/imm.13524. Epub 2022 Aug 10.
6
Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.
Inflamm Res. 2021 Jun;70(6):687-694. doi: 10.1007/s00011-021-01465-y. Epub 2021 May 6.
7
Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology.
mBio. 2022 Apr 26;13(2):e0313521. doi: 10.1128/mbio.03135-21. Epub 2022 Mar 1.
8
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection.
bioRxiv. 2020 Sep 21:2020.09.21.306837. doi: 10.1101/2020.09.21.306837.
9
Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2.
EBioMedicine. 2021 Feb;64:103228. doi: 10.1016/j.ebiom.2021.103228. Epub 2021 Feb 3.
10
COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.
Am J Respir Crit Care Med. 2022 Oct 15;206(8):961-972. doi: 10.1164/rccm.202107-1774OC.
引用本文的文献
1
Organokines in COVID-19: A Systematic Review.
Cells. 2023 May 9;12(10):1349. doi: 10.3390/cells12101349.
2
Increased Circulating Osteopontin Levels Promote Primary Tumour Growth, but Do Not Induce Metastasis in Melanoma.
Biomedicines. 2023 Mar 28;11(4):1038. doi: 10.3390/biomedicines11041038.
3
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters.
Int J Mol Sci. 2023 Apr 12;24(8):7099. doi: 10.3390/ijms24087099.
4
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.
Viruses. 2023 Feb 25;15(3):630. doi: 10.3390/v15030630.
5
Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure.
Sci Adv. 2022 Feb 25;8(8):eabm5900. doi: 10.1126/sciadv.abm5900.
6
Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study.
Exp Biol Med (Maywood). 2022 Jan;247(2):145-151. doi: 10.1177/15353702211046835. Epub 2021 Sep 26.
7
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19.
J Clin Med. 2021 Aug 30;10(17):3907. doi: 10.3390/jcm10173907.
Zotero 插件